{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-118953","form_type":"8-K","ticker":"STAA","cik":"0000718937","company_name":"STAAR SURGICAL CO","filed_at":"2024-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.899589+00:00","generated_at":"2026-05-30T08:41:15.776659+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"STAAR Surgical Q3 net sales up 10% to $88.6M; FY China growth outlook halved to 2%","bullets":["Net sales $88.6M (+10% YoY); net income $10.0M ($0.20 EPS) vs $4.8M ($0.10) prior year.","Gross margin 77.3% vs 79.2% due to lower production absorption; operating income $5.7M (6.4% of sales).","Adjusted EBITDA $16.2M ($0.33) vs $16.5M ($0.33); maintained FY net sales outlook $340-345M.","China growth outlook cut to ~2% from 10%; APAC 4% (prior 7%), Americas raised to 17% (15%).","Cash $236.0M; management calls China softness transitory, cites potential policy stimulus."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-118953","json":"https://secwatch.observer/filing/0000950170-24-118953.json","markdown":"https://secwatch.observer/filing/0000950170-24-118953.md","text":"https://secwatch.observer/filing/0000950170-24-118953.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/718937/000095017024118953/0000950170-24-118953-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/718937/000095017024118953/staa-20241030.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T08:41:15.776659+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}